Cassava Sciences, Inc. (SAVA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Cassava Sciences (SAVA) stock in focus as company posts better than expected Q3 earnings and reaffirms Phase 3 timeline for ...

Short SAVA slightly under 32.68, target 24.58, stop loss @ 32.77 Check the time stamp on this data. Updated AI-Generated ...

In terms of valuation, Cassava Sciences Inc’s market capitalization stands at $1.29 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

On Tuesday, Cassava Sciences Inc (SAVA) stock saw a decline, ending the day at $26.52 which represents a decrease of $-0.21 or -0.79% from the prior close of $26.73. The stock opened at $26.7 and ...

So here's Sava, a "multisensory healing experience" — AKA a human-size sound pod — that wants to improve your physical, ...

The second season of Percy Jackson and the Olympians has found its goddess of wisdom. Andra Day (The Deliverance) is the ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Singer Andra Day debuts as Athena in Disney's 'Percy Jackson and the Olympians' season two. The series, featuring Walker ...